Document is current
Any future updates will be listed below
-
Authors
Singleton, S. Parker https://orcid.org/0000-0002-7102-7820
Luppi, Andrea I. https://orcid.org/0000-0002-3461-6431
Carhart-Harris, Robin L.
Cruzat, Josephine https://orcid.org/0000-0002-3252-8657
Roseman, Leor
Nutt, David J. https://orcid.org/0000-0002-1286-1401
Deco, Gustavo https://orcid.org/0000-0002-8995-7583
Kringelbach, Morten L. https://orcid.org/0000-0002-3908-6898
Stamatakis, Emmanuel A. https://orcid.org/0000-0001-6955-9601
Kuceyeski, Amy https://orcid.org/0000-0002-5050-8342
- License Information
-
More Information
Article History
Received: 17 June 2021
Accepted: 22 September 2022
First Online: 3 October 2022
Competing interests
: R.L.C.-H. is an advisor to Beckley Psytech, Entheon Biomedical, TRYP Therapeutics, Mydecine, Usona Institute, Synthesis Institute, Osmind, Maya Health, and Journey Collab. D.J.N. is an advisory to COMPASSPathways, Neural Therapeutics, and Algernon Pharmaceuticals. All other authors declare no competing interests.
